Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination

Vaccine. 1995 Nov;13(16):1611-6. doi: 10.1016/0264-410x(95)00098-l.

Abstract

The levels of antibody against measles, mumps, and rubella were determined at 5-6 years postimmunization in 468 children vaccinated with two different trivalent vaccines. The proportions of children without detectable antibody levels were 12 and 3.6% for measles (p < 0.001), 14.9 and 7% for mumps (p = 0.006), and 3.3 and 3.1% for rubella (p = 0.88), respectively, in MMR II and Trivirix recipients. A higher proportion of those vaccinated at younger ages had undetectable or low levels of measles antibody. These data indicate that a large proportion of children vaccinated under routine conditions do not have detectable measles and mumps antibody.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Antibodies, Viral / blood*
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Male
  • Measles Vaccine / immunology
  • Measles Vaccine / therapeutic use*
  • Measles-Mumps-Rubella Vaccine
  • Mumps Vaccine / immunology
  • Mumps Vaccine / therapeutic use*
  • Rubella Vaccine / immunology
  • Rubella Vaccine / therapeutic use*
  • Time Factors
  • Vaccination
  • Vaccines, Combined / immunology
  • Vaccines, Combined / therapeutic use

Substances

  • Antibodies, Viral
  • Measles Vaccine
  • Measles-Mumps-Rubella Vaccine
  • Mumps Vaccine
  • Rubella Vaccine
  • Vaccines, Combined
  • rubella antibodies